While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every size
GLP-1 microdosing may represent part of this evolution, offering a more nuanced approach to metabolic health optimization
10.2147/dmso.S130834 [DOI] [PMC free article] [PubMed] [Google Scholar] Lind M., Hirsch I
Tirzepatide has been approved for T2D management - the mean HbA1c reduction in SURPASS programme ranged between 1.9 and 2.6% across the trials and 4069% of participants achieved 10% WL with the higher doses (10 and 15 mg), despite that there was no additional support for lifestyle intervention [16, 43]
Reduced food intake often means reduced electrolyte intake, which contributes to fatigue, headaches, and muscle cramps
By adding Wegovy to their Medicare formularies, plans may experience higher patient satisfaction ratings in their CAHPS (Consumer Assessment of Healthcare Providers and Systems) surveys in Rating of Drug Plans (D05 measure) and Getting Needed Prescription Drug (D06 measure)
